Moderna jumps on vaccine cancer breakthrough; stock tops 491% for year
Moderna (MRNA) stock is now up 491% for the year after surging 177% on Wednesday following its vaccine cancer breakthrough, according to the raw item.
MRNA stock is now up 491% for the year after surging 177% on Wednesday after its vaccine cancer breakthrough, second only to memory-storage company SNDK.
It’s the only non-tech play in the top five—DELL MU and STX complete the list.
Barron's notes its only the 2nd S&P 500 stock to jump more than 100% in a day in the past 25 years, with Hartford Insurance the last to do it in December 2008.